Abstract:ABSTRACT Phage therapy has become a viable antimicrobial treatment as an alternative to antibiotic treatment, with an increase in antibiotic resistance. Phage resistance is a major limitation in the therapeutic application of phages, and the lack of understanding of the dynamic changes between bacteria and phages constrains our response strategies to phage resistance. In this study, we investigated the changing trends of mutual resistance between Stenotrophomonas maltophilia ( S. maltophilia ) and its lytic phage, BUCT603. Our results revealed that S. maltophilia resisted phage infection through mutations in the cell membrane proteins, while the evolved phage re-infected the resistant strain primarily through mutations in structure-related proteins. Compared with the wild-type strain (SMA118), the evolved phage-resistant strain (R118-2) showed reduced virulence, weakened biofilm formation ability, and reduced resistance to aminoglycosides. In addition, the evolved phage BUCT603B1 in combination with kanamycin could inhibit the development of phage-resistant S. maltophilia in vitro and significantly improve the survival rate of S. maltophilia -infected mice. Altogether, these results suggest that in vitro characterization of bacteria-phage co-evolutionary relationships is a useful research tool to optimize phages for the treatment of drug-resistant bacterial infections. IMPORTANCE Phage therapy is a promising approach to treat infections caused by drug-resistant Stenotrophomonas maltophilia (S. maltophilia) . However, the rapid development of phage resistance has hindered the therapeutic application of phages. In vitro evolutionary studies of bacteria–phage co-cultures can elucidate the mechanism of resistance development between phage and its host. In this study, we investigated the resistance trends between S. maltophilia and its phage and found that inhibition of phage adsorption is the primary strategy by which bacteria resist phage infection in vitro , while phages can re-infect bacterial cells by identifying other adsorption receptors. Although the final bacterial mutants were no longer infected by phages, they incurred a fitness cost that resulted in a significant reduction in virulence. In addition, the combination treatment with phage and aminoglycoside antibiotics could prevent the development of phage resistance in S. maltophilia in vitro . These findings contribute to increasing the understanding of the co-evolutionary relationships between phages and S. maltophilia .

Characterization and genomic analysis of a lytic Stenotrophomonas maltophilia short-tailed phage A1432 revealed a new genus of the family Mesyanzhinovviridae

Biological Characteristics and Genomic Analysis of a Stenotrophomonas Maltophilia Phage Vb_smas_buct548

Biological Characterization and Complete Genome Analysis of a Novel Stenotrophomonas Maltophilia Phage Vb_sm_ytsc_ply2008005c.

Isolation, characterization, and genomic analysis of BUCT627: a lytic bacteriophage targeting Stenotrophomonas maltophilia

Characterization and genomic analysis of phage vB_SmaP_c9-N, a novel Stenotrophomonas maltophilia podophage with antibiofilm activity

Genomic Insights into the Phage-Defense Systems of Stenotrophomonas maltophilia Clinical Isolates

StM171, a Stenotrophomonas maltophilia Bacteriophage That Affects Sensitivity to Antibiotics in Host Bacteria and Their Biofilm Formation

Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model

Characterization and Genomic Analysis of a Novel Jumbo Bacteriophage vB_StaM_SA1 Infecting Staphylococcus aureus With Two Lysins

Characterization and complete genome sequence analysis of a novel virulent Siphoviridae phage against Staphylococcus aureus isolated from bovine mastitis in Xinjiang, China

Characterization and Genomic Analysis of Stutzerimonas Stutzeri Phage Vb_psts_zqg1, Representing a Novel Viral Genus.

Temperate Stutzerimonas Phage Encoding Toxin-Antitoxin System Genes Represents a Novel Genus

Characterization and genome analysis of the temperate bacteriophage φSAJS1 from Streptomyces avermitilis.

Isolation, Characterization, and Genomic Investigation of a Phytopathogenic Strain of Stenotrophomonas Maltophilia.

Isolation and molecular characterisation of Achromobacter phage phiAxp-3, an N4-like bacteriophage

Biological characterization and genomic analysis of a novel methicillin-resistant Staphylococcus aureus phage, SauPS-28

Comparative genomics analysis of Stenotrophomonas maltophilia strains from a community

The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants

Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia

Characteristic antimicrobial resistance of clinically isolated Stenotrophomonas maltophilia CYZ via complete genome sequence

Characterization and Genomic Analysis of a Novel Lytic Phage Vb_pstm_zrg1 Infecting Stutzerimonas Stutzeri, Representing a New Viral Genus, Elithevirus.